Organovo Holdings Inc (ONVO)
8.80
+0.24 +2.80%
NASDAQ
Jun 17, 16:14
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -2.43 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -16.83M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0% |
| Price and Valuation | |
| Market Cap | 76.54M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 21.12 |
| PE Ratio | -- |
| Price to Book Value | 1.953 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | -- |
| Free Cash Flow (Quarterly) | -2.225M |
| Return on Equity | Upgrade |
View All ONVO News
News
-
WireHeadlineTime (ET)
-
Yahoo06/15 11:38
-
SA Breaking News06/14 15:29
-
Yahoo06/01 16:39
-
SA Breaking News05/28 12:39
-
SA Breaking News05/28 12:11
-
SA Breaking News05/28 11:03
-
SA Breaking News04/21 11:01
-
Globe Newswire03/02 08:05
-
SA Breaking News02/25 08:25
-
SA Breaking News02/17 11:10
-
MT Newswires01/20 03:41
-
SA Breaking News12/28 12:39
-
SA Breaking News12/28 11:00
-
SA Breaking News12/22 11:00
-
SA Breaking News12/21 12:42
-
SA Breaking News12/18 12:39
-
SA Breaking News10/21 12:40
-
SA Breaking News10/12 10:58
-
SA Breaking News09/04 12:42
-
Globe Newswire09/03 16:05
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 08/10/2021 | Earnings Results | Q1 2022 Earnings Results |
| 02/08/2021 | Earnings Results | Q3 2021 Earnings Results |
| 11/05/2020 | Earnings Results | Q2 2021 Earnings Results |
| 09/15/2020 12:00 EST | AGM | 2020 Annual General Meeting |
| 08/19/2020 | Splits | 1 to 20 Split |
| 08/10/2020 | Earnings Results | Q1 2021 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.
- URL: http://www.organovo.com
- Investor Relations URL: http://ir.organovo.com/phoenix.zhtml?c=254194&p=irol-irhome
- HQ State/Province: California
- Sector: Healthcare
- Industry: Diagnostics & Research
- Equity Style: Small Cap/Value
- Next Earnings Release: Aug. 10, 2021
- Last Earnings Release: Feb. 08, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 8.80 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ONVO Tweets Stocktwits
Advertisement
